Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.
Stella F, Chiappella A, Magni M, Bonifazi F, De Philippis C, Musso M, Cutini I, Ljevar S, Barbui AM, Farina M, Martino M, Massaia M, Grillo G, Angelillo P, Botto B, Patriarca F, Krampera M, Arcaini L, Tisi MC, Zinzani P, Sorà F, Bramanti S, Pennisi M, Carniti C, Corradini P. Stella F, et al. Among authors: de philippis c. Br J Haematol. 2024 Dec 22. doi: 10.1111/bjh.19961. Online ahead of print. Br J Haematol. 2024. PMID: 39710966
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas.
Dodero A, Bramanti S, Di Trani M, Pennisi M, Ljevar S, Chiappella A, Massimo M, Guidetti A, Corrado F, Nierychlewska PM, Di Rocco A, Lorenzini D, Daoud R, De Philippis C, Santoro A, Carlo-Stella C, Corradini P. Dodero A, et al. Among authors: de philippis c. Br J Haematol. 2024 Jan;204(1):151-159. doi: 10.1111/bjh.19057. Epub 2023 Sep 10. Br J Haematol. 2024. PMID: 37690811 Free article.
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.
Bramanti S, Mannina D, Chiappella A, Casadei B, De Philippis C, Giordano L, Navarria P, Mancosu P, Taurino D, Scorsetti M, Carlo-Stella C, Zinzani P, Santoro A, Corradini P. Bramanti S, et al. Among authors: de philippis c. Bone Marrow Transplant. 2025 Jan;60(1):32-38. doi: 10.1038/s41409-024-02427-8. Epub 2024 Oct 9. Bone Marrow Transplant. 2025. PMID: 39384870
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma.
De Philippis C, Zucchinetti C, Mannina D, Krampera M, Zinzani PL, Chiappella A, di Rocco A, Orcioulo E, Tisi MC, Pistolese F, Giordano L, Santoro A, Bramanti S. De Philippis C, et al. Bone Marrow Transplant. 2024 Apr;59(4):569-571. doi: 10.1038/s41409-024-02205-6. Epub 2024 Jan 25. Bone Marrow Transplant. 2024. PMID: 38272998 No abstract available.
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi.
Arcari A, Morello L, Vallisa D, Marcheselli L, Tecchio C, Quaglia FM, Tisi MC, Zilioli VR, Di Rocco A, Perrone T, Gini G, Dogliotti I, Bianchetti N, Bozzoli V, De Philippis C, Alvarez De Celis MI, Chiappella A, Fabbri A, Pelosini M, Merli M, Molinari AL, Sciarra R, Volpetti S, Hohaus S, Nassi L, Visco C. Arcari A, et al. Among authors: de philippis c. Leuk Lymphoma. 2021 Dec;62(14):3474-3483. doi: 10.1080/10428194.2021.1961238. Epub 2021 Oct 8. Leuk Lymphoma. 2021. PMID: 34625013
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas.
Castagna L, Dodero A, Patriarca F, Onida F, Olivieri A, Russo D, Giordano L, Majolino I, Bramanti S, Mariotti J, Sarina B, De Philippis C, Farina L, Carlo-Stella C, Corradini P, Santoro A. Castagna L, et al. Among authors: de philippis c. Transplant Cell Ther. 2021 Apr;27(4):328.e1-328.e6. doi: 10.1016/j.jtct.2021.01.007. Epub 2021 Jan 17. Transplant Cell Ther. 2021. PMID: 33836877 Free article. Clinical Trial.
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide.
Mussetti A, De Philippis C, Carniti C, Bastos-Oreiro M, Gayoso J, Cieri N, Pennisi M, Ciceri F, Greco R, Peccatori J, Patriarca F, Mariotti J, Castagna L, Corradini P. Mussetti A, et al. Among authors: de philippis c. Bone Marrow Transplant. 2018 Dec;53(12):1522-1531. doi: 10.1038/s41409-018-0183-8. Epub 2018 Apr 27. Bone Marrow Transplant. 2018. PMID: 29703966
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Mariotti J, De Philippis C, Bramanti S, Sarina B, Tordato F, Pocaterra D, Casari E, Carlo-Stella C, Santoro A, Castagna L. Mariotti J, et al. Among authors: de philippis c. Eur J Haematol. 2019 Apr;102(4):357-367. doi: 10.1111/ejh.13214. Epub 2019 Feb 13. Eur J Haematol. 2019. PMID: 30672611 Free PMC article.
66 results